Change search
ReferencesLink to record
Permanent link

Direct link
Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment.
Umeå University, Faculty of Medicine, Clinical Sciences.
Show others and affiliations
1997 In: Antimicrobial Agents and Chemotherapy, Vol. 41, no 9, 1979-1984 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
1997. Vol. 41, no 9, 1979-1984 p.
URN: urn:nbn:se:umu:diva-3105OAI: diva2:141572
Available from: 2003-11-27 Created: 2003-11-27Bibliographically approved
In thesis
1. Experimental acute otitis media: aspects on treatment, protection and structural changes
Open this publication in new window or tab >>Experimental acute otitis media: aspects on treatment, protection and structural changes
2003 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Acute otitis media (AOM) is a common disease in childhood and is one of the most common causes for outpatient antibiotic treatment. The major aetiological agents of AOM have varied over the decades. Now the three most common pathogens are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. The resistance patterns of these organisms have also varied from the beginning of the antibiotic era to the situation we have today with an increasing incidence of penicillin-resistant S. pneumoniae and a moderate to high frequency of beta-lactamase production in H. influenzae and M. catarrhalis. In Sweden we have continued to use the Scandinavian treatment policy of penicillins as the first-line antibiotic treatment of AOM, which has been implemented with good results in the past. The question is if this policy will continue to have acceptable treatment results.

In order to investigate aspects of treatment, protection and structural changes in AOM, an animal model was used.

Amoxicillin treatment of AOM caused by H. influenzae was studied. Amoxicillin treatment was shown to shorten the duration of the infection and to reduce the morphological changes normally observed after an untreated AOM. The influence of antibiotic treatment on recurrent AOM was evaluated. Amoxicillin treatment did not lead to less protection against reinfection. Abstaining from antibiotics did not improve the levels of serum IgG antibodies. The IgG levels were significantly higher in treated animals after rechallenge. AOM caused by H. influenzae with a non-beta-lactamase-mediated resistance to beta-lactams was investigated and it was observed that during amoxicillin treatment the chromosomal changes mediating resistance were possibly advantageous for the bacterium. In cultures from children with AOM, there is sometimes growth of several bacteria. The possibility of a sheltering effect of beta-lactamase-producing H. influenzae on a penicillin-sensitive S. pneumoniae in a mixed infection was investigated, and amoxicillin was shown to eradicate the pneumococci from the middle ear despite the presence of beta-lactamase. An increasingly cultured bacterium in nasopharynx and in AOM is M. catarrhalis. It is now beta-lactamase-producing in almost 100% of cases and is thus not eradicated by penicillins. An animal model of AOM caused by beta-lactamase-producing M. catarrhalis was established to study the course of this infection with the possibility of evaluating aspects of virulence between AOM pathogens. The AOM observed was a self-limiting disease.

The results obtained in this study in a rat model support the continuing use of penicillins as first-line drugs in the treatment of AOM. Penicillins are not sufficient to treat all causative agents, but the majority of pathogens including the most virulent bacteria are eradicated from the middle ear.

Place, publisher, year, edition, pages
Umeå: Umeå university, 2003. 57 p.
Umeå University medical dissertations, ISSN 0346-6612 ; 868
Otorhinolaryngology, acute otitis media, penicillins, rat, treatment, protection, beta-lactamase, Moraxella catarrhalis, Haemophilus influenzae, Otorhinolaryngologi
National Category
Research subject
urn:nbn:se:umu:diva-162 (URN)91-7305-569-7 (ISBN)
Public defence
2003-12-12, Sal B (Rosa salen), Byggnad 1D, Tandläkarhögskolan, 9 tr, NUS, Umeå, 13:00
Available from: 2003-11-27 Created: 2003-11-27 Last updated: 2011-04-08Bibliographically approved

Open Access in DiVA

No full text

Other links
By organisation
Clinical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 54 hits
ReferencesLink to record
Permanent link

Direct link